| Drug Type CAR-T | 
| Synonyms | 
| Target | 
| Action modulators | 
| Mechanism CD123 modulators(Interleukin-3 receptor subunit alpha modulators), CD33 modulators(Myeloid cell surface antigen CD33 modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1/2 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Adult Acute Myeloblastic Leukemia | Phase 2 | China  | 10 Jul 2024 | |
| Refractory acute myeloid leukemia | Phase 2 | China  | 10 Jul 2024 | 





